What is the Y-tunnus number of GlaxoSmithKline Oy?

GlaxoSmithKline Oy is registered with PRH / YTJ under Y-tunnus 0108378-4.

What is the revenue of GlaxoSmithKline Oy?

GlaxoSmithKline Oy reported revenue of EUR 77,6M in 2025.

How many employees does GlaxoSmithKline Oy have?

GlaxoSmithKline Oy employs 86 people as of the latest annual report.

Who is the CEO of GlaxoSmithKline Oy?

Robert Håkan Kajander is Audit of GlaxoSmithKline Oy, in role since 2021.

Who is the chairman of GlaxoSmithKline Oy?

Anne Margaret Belcher chairs the board of GlaxoSmithKline Oy, in role since 2020.

Where is GlaxoSmithKline Oy headquartered?

GlaxoSmithKline Oy's registered address is Porkkalankatu 20-A.

Riskpilot← Back to search

Sign inGet full access

GlaxoSmithKline Oy

OYActive

Y-tunnus 0108378-4Porkkalankatu 20A, 00180 HelsinkiWholesale of pharmaceutical and medical goods · NACE 4646Est. 197086 employees

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2021	2022	2023	2024	2025
Revenue	68 561	77 647	79 804	78 090	77 617
Staff expenses	−21 728	−22 216	−0	−0	−0
EBITDA	2 988	3 015	3 634	2 735	2 587
Depreciation & amort.	−684	−490	−0	−0	−0
EBIT	2 304	2 525	3 634	2 735	2 587
Net financials	−23	−17	182	268	1
Profit before tax	2 281	2 508	3 816	3 003	2 588
Tax	521	567	780	624	479
Net profit	1 760	1 941	3 036	2 378	2 109

Balance sheet

EUR thousands

Item	2021	2022	2023	2024	2025
Total assets	27 880	25 157	21 924	23 763	21 783
Equity	8 804	9 046	10 181	9 560	9 369
Long-term debt	—	—	0	0	0
Short-term debt	19 077	16 112	11 742	14 203	12 414
Total debt	19 077	16 112	11 742	14 203	12 414

Financial ratios

5-year trend

EBITDA margin

3.3%

This company

15.8%

Market median

-79% vs market

20212025

Equity ratio

43.0%

This company

38.2%

Market median

+13% vs market

20212025

Return on equity

22.5%

This company

18.4%

Market median

+22% vs market

20212025

Net profit margin

2.7%

This company

8.1%

Market median

-67% vs market

20212025

Asset turnover

3.56×

This company

1.12×

Market median

+218% vs market

20212025

Debt / equity

1.33×

This company

0.62×

Market median

-115% vs market

20212025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View PDF

GlaxoSmithKline Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on GlaxoSmithKline Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on GlaxoSmithKline Oy